Andrew Jaeyoung Synn, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 2 | 2021 | 1585 | 0.660 |
Why?
|
Respiratory Function Tests | 2 | 2020 | 1685 | 0.600 |
Why?
|
Lung | 4 | 2022 | 9979 | 0.570 |
Why?
|
Pulmonary Emphysema | 2 | 2019 | 683 | 0.560 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 3200 | 0.440 |
Why?
|
Pulmonary Veins | 1 | 2019 | 743 | 0.430 |
Why?
|
Tobacco Smoke Pollution | 1 | 2019 | 820 | 0.430 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1331 | 0.420 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 918 | 0.380 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1927 | 0.350 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2630 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20600 | 0.310 |
Why?
|
Research Design | 2 | 2024 | 6178 | 0.300 |
Why?
|
Longitudinal Studies | 5 | 2023 | 14607 | 0.290 |
Why?
|
Vital Capacity | 2 | 2019 | 970 | 0.270 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6340 | 0.260 |
Why?
|
Spirometry | 2 | 2019 | 928 | 0.260 |
Why?
|
Forced Expiratory Volume | 2 | 2019 | 1813 | 0.230 |
Why?
|
Radius Fractures | 1 | 2008 | 514 | 0.210 |
Why?
|
Ventilator Weaning | 1 | 2021 | 164 | 0.170 |
Why?
|
Linear Models | 2 | 2019 | 5869 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13382 | 0.160 |
Why?
|
Occupations | 1 | 2020 | 516 | 0.150 |
Why?
|
Temperature | 1 | 2024 | 2219 | 0.150 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 638 | 0.140 |
Why?
|
Prognosis | 3 | 2023 | 29672 | 0.140 |
Why?
|
Organ Size | 1 | 2019 | 2253 | 0.110 |
Why?
|
Heart Rate | 1 | 2024 | 4196 | 0.100 |
Why?
|
Qualitative Research | 1 | 2023 | 3016 | 0.100 |
Why?
|
Air Pollution | 1 | 2024 | 2351 | 0.090 |
Why?
|
Air Pollutants | 1 | 2024 | 2889 | 0.090 |
Why?
|
Algorithms | 2 | 2021 | 14023 | 0.080 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11118 | 0.080 |
Why?
|
Humans | 12 | 2024 | 761098 | 0.080 |
Why?
|
Middle Aged | 6 | 2024 | 220835 | 0.080 |
Why?
|
Aged | 5 | 2024 | 169266 | 0.070 |
Why?
|
Risk Factors | 3 | 2021 | 74219 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12467 | 0.070 |
Why?
|
Hand Strength | 1 | 2008 | 456 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12058 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9278 | 0.060 |
Why?
|
Asthma | 1 | 2024 | 6229 | 0.060 |
Why?
|
Male | 6 | 2024 | 360675 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39121 | 0.060 |
Why?
|
Female | 6 | 2024 | 392458 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13506 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9055 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 9001 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3419 | 0.050 |
Why?
|
Particulate Matter | 2 | 2024 | 2597 | 0.050 |
Why?
|
Range of Motion, Articular | 1 | 2008 | 1590 | 0.050 |
Why?
|
Nitrogen Dioxide | 1 | 2024 | 521 | 0.050 |
Why?
|
Ozone | 1 | 2024 | 482 | 0.050 |
Why?
|
Dust | 1 | 2024 | 486 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58946 | 0.050 |
Why?
|
Risk Assessment | 1 | 2021 | 24013 | 0.040 |
Why?
|
Regression Analysis | 1 | 2008 | 6343 | 0.040 |
Why?
|
Prospective Studies | 1 | 2023 | 54419 | 0.040 |
Why?
|
Recovery of Function | 1 | 2008 | 2981 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 6975 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2022 | 838 | 0.040 |
Why?
|
Young Adult | 1 | 2023 | 59199 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2022 | 1866 | 0.030 |
Why?
|
Dyspnea | 1 | 2024 | 1347 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 41486 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2023 | 80673 | 0.030 |
Why?
|
Exercise Test | 1 | 2022 | 2165 | 0.030 |
Why?
|
Adult | 3 | 2024 | 221083 | 0.030 |
Why?
|
Oxygen | 1 | 2022 | 4226 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2024 | 4479 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10213 | 0.020 |
Why?
|
Quality of Life | 1 | 2024 | 13362 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2008 | 64670 | 0.010 |
Why?
|